C1QTNF9 and inflammation: CTRP9 acts via Adipo R1 receptors stimulating NO production in endothelial cells and endothelial dependent vasodilatation CTRP9 reduces endothelial inflammation and oxidative damage using the AdipoR1/AMPK activation pathway [57].